The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancer.
The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancer.
复制标题
DOI:
10.1038/ncb3295
复制
发表时间:
2016-02
影响因子:
21.3
通讯作者:
Yang L
中科院分区:
文献类型:
--
作者:
Lin A;Li C;Xing Z;Hu Q;Liang K;Han L;Wang C;Hawke DH;Wang S;Zhang Y;Wei Y;Ma G;Park PK;Zhou J;Zhou Y;Hu Z;Zhou Y;Marks JR;Liang H;Hung MC;Lin C;Yang L
Although long noncoding RNAs (lncRNAs) predominately reside in nuclear and exert their functions in many biological processes, their potential involvement in cytoplasmic signal transduction remains unexplored. Here, we identified a cytoplasmic lncRNA, Long-Intergenic Noncoding RNA for Kinase Activation (LINK-A), which mediates HB-EGF triggered, EGFR:GPNMB heterodimer-dependent HIF1α phosphorylation at Tyr565 and Ser797 by BRK and LRRK2 respectively. These events cause HIF1α stabilization, HIF1α-p300 interaction, and activation of HIF1α transcriptional programs under normoxic conditions. Mechanistically, LINK-A facilitates the recruitment of BRK to EGFR:GPNMB complex and BRK kinase activation. The BRK-dependent HIF1α Tyr565 phosphorylation interferes with Pro564 hydroxylation, leading to normoxic HIF1α stabilization. Both LINK-A and LINK-A-dependent signaling pathway activation correlate with TNBC, promoting breast cancer glycolysis reprogramming and tumorigenesis. Our findings illustrate the magnitude and diversity of cytoplasmic lncRNAs in signal transduction and highlight the important roles of lncRNAs in cancer.